Strumento inattivo

Azioni Entellus Medical Inc

Azioni

Durata

Periodo

Stile

Multi-Center Market Research Confirms Nasal Valve Collapse as a Contributor for Most Nasal Obstruction Sufferers	28/06/18
Entellus Medical announces publication of the 1-year results of a randomized controlled trial comparing balloon dilation with medical therapy for treatment of persistent Eustachian tube dysfunction	19/06/18
Entellus Medical Announces Multi-Center Clinical Study Publication Confirming Nasal Obstruction Symptom Improvement from LATERA	31/05/18
Entellus Medical Announces Definitive Agreement to be Acquired by Stryker Corporation for a Purchase Price of $24.00 Per Share in Cash	07/12/17
Entellus Medical to Participate in Upcoming Investor Conferences	14/11/17

Dirigenti	Titolo	Età	Da
James Pierce CEO	Chief Executive Officer	-	-

Settore

	Variaz. 1 gen.	Capi.
SHOCKWAVE MEDICAL, INC.	+73,37%	12,41 Mrd
PENUMBRA, INC.	-18,59%	8,23 Mrd
MASIMO CORPORATION	-0,90%	6,46 Mrd
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+15,76%	5,5 Mrd
GETINGE AB	-4,95%	5,33 Mrd
APT MEDICAL INC.	+40,80%	5,1 Mrd
ASAHI INTECC CO., LTD.	-18,32%	4,05 Mrd
INARI MEDICAL, INC.	-29,79%	2,54 Mrd
SHENZHEN YHLO BIOTECH CO., LTD.	+7,56%	1,99 Mrd